Active Biotech AB (publ) (STO:ACTI)
Sweden · Delayed Price · Currency is SEK 5.66
+0.03 (0.44%)
Jul 3, 2026, 5:29 PM CET
Active Biotech AB Market Cap
Active Biotech AB has a market cap or net worth of 149.07 million as of July 2, 2026. Its market cap has decreased by -44.41% in one year.
Market Cap
149.07M
Enterprise Value
95.87M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.66
Market Cap Chart
Since March 11, 1998, Active Biotech AB's market cap has increased from 6.93M to 149.07M, an increase of 2,050.95%. That is a compound annual growth rate of 11.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 149.07M | 22.93% |
| Dec 30, 2025 | 121.26M | 4.60% |
| Dec 30, 2024 | 115.93M | -29.80% |
| Dec 29, 2023 | 165.13M | -35.20% |
| Dec 30, 2022 | 254.82M | -7.51% |
| Dec 30, 2021 | 275.52M | 0.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elicera Therapeutics AB | 195.54M |
| IRLAB Therapeutics AB | 191.84M |
| Initiator Pharma | 190.98M |
| Xintela AB | 175.70M |
| Diamyd Medical AB | 168.93M |
| Nanologica AB | 163.07M |
| Simris Group AB (PUBL) | 120.94M |
| NextCell Pharma AB | 120.07M |